| Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells E Ersvaer, K Liseth, J Skavland, BT Gjertsen, Ø Bruserud BMC immunology 11, 1-12, 2010 | 96 | 2010 |
| Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53 JM Irish, N Ånensen, R Hovland, J Skavland, AL Børresen-Dale, ... Blood 109 (6), 2589-2596, 2007 | 75 | 2007 |
| Access to the spleen microenvironment through lymph shows local cytokine production, increased cell flux, and altered signaling of immune cells during lipopolysaccharide … E Semaeva, O Tenstad, J Skavland, M Enger, PO Iversen, BT Gjertsen, ... The Journal of Immunology 184 (8), 4547-4556, 2010 | 61 | 2010 |
| Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status … H Reikvam, KJ Hatfield, E Ersvaer, R Hovland, J Skavland, BT Gjertsen, ... British journal of haematology 156 (4), 468-480, 2012 | 57 | 2012 |
| Lentinan: hematopoietic, immunological, and efficacy studies in a syngeneic model of acute myeloid leukemia E McCormack, J Skavland, M Mujić, Ø Bruserud, BT Gjertsen Nutrition and cancer 62 (5), 574-583, 2010 | 57 | 2010 |
| Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial … T Bredholt, EAO Dimba, HR Hagland, L Wergeland, J Skavland, ... Molecular cancer 8, 1-13, 2009 | 57 | 2009 |
| Effects of interferon gamma on native human acute myelogenous leukaemia cells E Ersvaer, J Skavland, E Ulvestad, BT Gjertsen, Ø Bruserud Cancer Immunology, Immunotherapy 56, 13-24, 2007 | 43 | 2007 |
| Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis G Gausdal, A Wergeland, J Skavland, E Nguyen, F Pendino, N Rouhee, ... Cell Death & Disease 4 (2), e516-e516, 2013 | 36 | 2013 |
| Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib SE Gullaksen, J Skavland, S Gavasso, V Tosevski, K Warzocha, ... haematologica 102 (8), 1361, 2017 | 33 | 2017 |
| Single-cell proteomics: potential implications for cancer diagnostics S Gavasso, SE Gullaksen, J Skavland, BT Gjertsen Expert review of molecular diagnostics 16 (5), 579-589, 2016 | 29 | 2016 |
| Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia J Skavland, KM Jørgensen, K Hadziavdic, R Hovland, I Jonassen, ... Blood cancer journal 1 (2), e4-e4, 2011 | 27 | 2011 |
| Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells-high expression is associated with adverse prognosis as well as altered … Ø Bruserud, H Reikvam, H Fredly, J Skavland, KM Hagen, TT Van Hoang, ... Oncotarget 6 (5), 2794, 2015 | 23 | 2015 |
| Acute myelogenous leukemia in a patient with Li–Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report N Ånensen, J Skavland, C Stapnes, A Ryningen, AL Børresen-Dale, ... Leukemia 20 (4), 734-736, 2006 | 21 | 2006 |
| Signaling effects of sodium hydrosulfide in healthy donor peripheral blood mononuclear cells A Sulen, SE Gullaksen, L Bader, DW McClymont, J Skavland, S Gavasso, ... Pharmacological Research 113, 216-227, 2016 | 20 | 2016 |
| Titrating complex mass cytometry panels SE Gullaksen, L Bader, M Hellesøy, A Sulen, OHE Fagerholt, CB Engen, ... Cytometry Part A 95 (7), 792-796, 2019 | 18 | 2019 |
| Whole blood preservation methods alter chemokine receptor detection in mass cytometry experiments ST Sakkestad, J Skavland, K Hanevik Journal of immunological methods 476, 112673, 2020 | 17 | 2020 |
| Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic, and transcriptomic … I Nepstad, KJ Hatfield, E Aasebø, M Hernandez-Valladares, AK Brenner, ... Expert Opinion on Therapeutic Targets 22 (7), 639-653, 2018 | 16 | 2018 |
| In vitro screening for putative psoriasis‐specific antigens among wheat proteins and peptides J Skavland, PR Shewry, J Marsh, B Geisner, JA Marcusson British Journal of Dermatology 166 (1), 67-73, 2012 | 16 | 2012 |
| Targeted Therapy of FLT3 in Treatment of AML—Current Status and Future Directions CBN Engen, L Wergeland, J Skavland, BT Gjertsen Journal of Clinical Medicine 3 (4), 1466-1489, 2014 | 15 | 2014 |
| Untangling the intracellular signalling network in cancer—A strategy for data integration in acute myeloid leukaemia KM Jørgensen, SM Hjelle, OK Øye, P Puntervoll, H Reikvam, J Skavland, ... Journal of proteomics 74 (3), 269-281, 2011 | 14 | 2011 |
